Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

NCT02337842 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Gastroenteritis Norovirus

Interventions

BIOLOGICAL: Norovirus GII.4 Challenge Pool CIN-1
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)